IRIS
GNETTI, Letizia
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.211
AS - Asia 3.100
EU - Europa 2.567
SA - Sud America 538
AF - Africa 180
Continente sconosciuto - Info sul continente non disponibili 3
OC - Oceania 2
Totale 10.601
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.104
SG - Singapore 1.356
CN - Cina 953
IT - Italia 636
IE - Irlanda 438
BR - Brasile 418
SE - Svezia 408
HK - Hong Kong 258
DE - Germania 232
VN - Vietnam 188
FR - Francia 126
NL - Olanda 118
ZA - Sudafrica 111
GB - Regno Unito 103
AT - Austria 99
RU - Federazione Russa 97
FI - Finlandia 95
IN - India 77
TR - Turchia 65
CA - Canada 56
AR - Argentina 49
UA - Ucraina 44
BE - Belgio 43
BD - Bangladesh 35
CI - Costa d'Avorio 33
MX - Messico 33
CZ - Repubblica Ceca 30
PL - Polonia 29
EC - Ecuador 28
KR - Corea 27
IQ - Iraq 24
JP - Giappone 23
ES - Italia 21
ID - Indonesia 19
CO - Colombia 13
PK - Pakistan 13
LT - Lituania 11
CL - Cile 8
EG - Egitto 8
IL - Israele 8
KZ - Kazakistan 7
PY - Paraguay 7
VE - Venezuela 7
CH - Svizzera 6
KE - Kenya 6
MA - Marocco 6
UZ - Uzbekistan 6
AZ - Azerbaigian 5
TN - Tunisia 5
AL - Albania 4
BY - Bielorussia 4
JO - Giordania 4
PA - Panama 4
SA - Arabia Saudita 4
AE - Emirati Arabi Uniti 3
AM - Armenia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
HU - Ungheria 3
IR - Iran 3
NG - Nigeria 3
PE - Perù 3
PH - Filippine 3
PS - Palestinian Territory 3
PT - Portogallo 3
BG - Bulgaria 2
BH - Bahrain 2
BO - Bolivia 2
BW - Botswana 2
CG - Congo 2
CR - Costa Rica 2
HN - Honduras 2
HR - Croazia 2
KW - Kuwait 2
LK - Sri Lanka 2
MY - Malesia 2
NO - Norvegia 2
PR - Porto Rico 2
RO - Romania 2
SV - El Salvador 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AU - Australia 1
BB - Barbados 1
ET - Etiopia 1
EU - Europa 1
GD - Grenada 1
GR - Grecia 1
GY - Guiana 1
IS - Islanda 1
JM - Giamaica 1
KG - Kirghizistan 1
LB - Libano 1
LV - Lettonia 1
MN - Mongolia 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
RS - Serbia 1
Totale 10.599
Salva come PNG Salva come JPEG
Città #
Singapore 740
Ashburn 652
Chandler 552
Dallas 448
Dublin 434
Santa Clara 291
Hong Kong 257
Beijing 227
Parma 173
Ann Arbor 160
Boardman 159
New York 149
Shanghai 118
Los Angeles 113
Johannesburg 104
Munich 94
Dearborn 87
Hefei 87
Vienna 84
Ho Chi Minh City 76
Nanjing 66
Princeton 65
Chicago 58
Hanoi 49
Milan 44
Moscow 44
Izmir 43
Rio Saliceto 40
Helsinki 38
Brussels 37
São Paulo 37
Jacksonville 36
Wilmington 35
Jinan 34
Abidjan 32
Bremen 32
Columbus 32
Bologna 30
The Dalles 28
Seoul 27
Buffalo 26
Marseille 24
Seattle 23
Chennai 22
Montreal 22
Nuremberg 22
Tianjin 22
Warsaw 22
Des Moines 21
Frankfurt am Main 21
Denver 20
Guangzhou 19
London 19
Modena 19
Tokyo 19
Hebei 18
Kunming 18
Turku 18
Houston 17
San Mateo 17
Toronto 17
Changsha 16
San Jose 16
West Jordan 16
Atlanta 15
Council Bluffs 15
Fremont 15
Jakarta 15
Shenyang 15
Bengaluru 14
Brno 13
Brooklyn 13
Curitiba 13
Phoenix 13
Poplar 12
Redondo Beach 12
Rio de Janeiro 12
San Francisco 12
Belo Horizonte 11
Jiaxing 11
Redwood City 11
Reggio Emilia 11
Boston 10
Guayaquil 10
Haiphong 10
Norwalk 10
Stockholm 10
Woodbridge 10
Baghdad 9
Manchester 9
Mexico City 9
Nanchang 9
Orem 9
Rome 9
Amsterdam 8
Erbil 8
Pune 8
Ankara 7
Charlotte 7
Contagem 7
Totale 6.678
Salva come PNG Salva come JPEG
Nome #
PD-L1 overexpression induces STAT signaling and promotes the secretion of pro-angiogenic cytokines in non-small cell lung cancer (NSCLC) 205
Isolation and characterization of circulating tumor cells in advanced squamous-cell carcinoma of the lung 188
Validation of a radiomic approach to decipher NSCLC immune microenvironment in surgically resected patients 182
Correlations between tumor-infiltrating and circulating lymphocyte subpopulations in advanced renal cancer patients treated with nivolumab 176
227P Sexual dimorphism in immune profile of early and advanced NSCLC 173
MESENCHYMAL STROMAL CELLS ISOLATED FROM DEFINED NSCLC CONTEXTURES REPRODUCE THE IMMUNE SIGNATURE OF THE PARENTAL MICROENVIRONMENT 170
Solid-phase microextraction coupled to gas chromatography mass spectrometry followed by multivariate data analysis for the identification of volatile organic compounds as possible biomarkers in lung cancer tissues 168
Leiomioma metastatizzante benigno gigante 166
High levels of Notch intracellular cleaved domain are associated with stemness and reduced bevacizumab efficacy in patients with advanced colon cancer 155
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology? 154
PREDICTIVE AND PROGNOSTIC VALUE OF CLINICAL AND MOLECULAR FEATURES IN PATIENTS UNDERGOING PULMONARY METASTASECTOMY FROM RENAL CELL CARCINOMA 154
Early fetal akinesia sequence: A case report with unusual autoptic features 152
INTEGRATION OF TISSUE PD-1/PD-L1 IMMUNE CHECKPOINT WITH COMPUTED TOMOGRAPHY (CT) BASED TEXTURE ANALYSIS EXHIBITS HIGH PROGNOSTIC IMPACE ON SURGICALLY RESECTED NON SMALL CELL LUNG CANCER (NSCLC) 150
Pulmonary metastasectomy for colorectal cancer: Analysis of prognostic factors affecting survival 149
Human Papilloma Virus (HPV) status, P16INK4a and p53 overexpression in epithelial malignant and borderline ovarian neoplasms 148
189P The parallel interrogation of tissue and peripheral blood immune features unveils a bidirectional crosstalk with clinical impact on resected NSCLC 147
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer 147
The role of miRNA-221 and miRNA-126 in patients with benign metastasizing leiomyoma of the lung: an overview with new interesting scenarios 147
Immunomodulatory effects of antiangiogenic tyrosine kinase inhibitors in renal cell carcinoma models: Impact on following anti-PD-1 treatments 146
Widespread Nivolumab-induced Enteropathy in a Long Responder Non–Small-cell Lung Cancer Patient 142
Endometrial mucinous microglandular adenocarcinoma: morphologic, immunohistochemical features and emphasis in the HPV status 140
Computed tomography - histology correlations of unusual lung tumors 140
A pulmonary infection by Actinomyces odontolyticus and Veillonella atypica in an immunocompetent patient with dental caries 140
Kidney Biopsy Findings in a Critically Ill COVID-19 Patient With Dialysis-Dependent Acute Kidney Injury: A Case Against “SARS-CoV-2 Nephropathy 139
Pleural tuberculosis: medical thoracoscopy greatly increases the diagnostic accuracy 134
Dataset on the identification of a prognostic radio-immune signature in surgically resected Non Small Cell Lung Cancer 134
Lung Toxicity in Non-Small-Cell Lung Cancer Patients Exposed to ALK Inhibitors: Report of a Peculiar Case and Systematic Review of the Literature 132
2315P Clinical and blood immune-inflammatory profiling to decode different patterns of acquired resistance in immunotherapy treated NSCLC patients 129
Pili canaliculi: a familial study 129
1929O Soluble PD-L1 and circulating CD8+PD1+ and NK cells enclose a highly prognostic and predictive immune effector score in immunotherapy treated NSCLC patients 128
From the beginning to resistance: Study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC 127
Prognostic value of [18F]FDG PET/CT parameters in surgically resected primary lung adenocarcinoma: a single-center experience 127
Spatial architecture of tumour-infiltrating lymphocytes as a prognostic parameter in resected non-small-cell lung cancer 125
Immune context characterization and heterogeneity in primary tumors and pulmonary metastases from renal cell carcinoma 125
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies 123
EXCEPTIONAL EVOLUTION OF BENIGN METASTASIZING LEIOMYOMAS OF THE LUNG 122
Multiple primary malignancies involving lung cancer: a single-center experience 122
KRAS: A Druggable Target in Colon Cancer Patients 122
Intersecting Blood Cytokines With Cholesterol Parameters to Profile Patients With Advanced Solid Tumors Receiving Immune Checkpoint Inhibitors 118
Integrated CT imaging and tissue immune features disclose a radio-immune signature with high prognostic impact on surgically resected NSCLC 118
Sarcoid-like reaction mimicking disease progression in an ALK-positive lung cancer patient receiving lorlatinib 118
Emergence of a HER2-amplified clone during disease progression in an ALK-rearranged NSCLC patient treated with ALK-inhibitors: A case report 118
Giant intercostal nerve schwannoma in a patient with neurofibromatosis type 2 117
METACHRONOUS AND SYNCHRONOUS OCCURRENCE OF PRIMARY MALIGNANCIES IN PATIENTS WITH RESECTED NON SMALL CELL LUNG CANCER (NSCLC): A RETROSPECTIVE OBSERVATIONAL STUDY 115
A case of Solitary fibrous pleura tumor associated with severe hypoglycemia: the Doege-Potter 's Syndrome 115
Concurrent Acquired BRAF V600E Mutation and MET Amplification as Resistance Mechanism of First-Line Osimertinib Treatment in a Patient with EGFR-Mutated NSCLC 114
Analysis of a panel of druggable gene mutations and of ALK and PD-L1 expression in a series of thymic epithelial tumors (TETs) 114
Retrospective immunophenotypical evaluation of MET, PD-1/PD-L1, and mTOR pathways in primary tumors and pulmonary metastases of renal cell carcinoma: the RIVELATOR study addresses the issue of biomarkers heterogeneity 113
TUMOR-INFILTRATING LYMPHOCYTES, PDL-1, BAP-1, VEGFR-2 AND IGF-1R EXPRESSION IN MALIGNANT PLEURAL MESOTHELIOMA 113
SURGICAL SAMPLING IS AN EMERGING ISSUE IN THE ASSESSMENT OF THE IMMUNE CONTEXTURE IN NON SMALL CELL LUNG CANCER (NSCLC) 110
Monitoring cfDNA in plasma and in other liquid biopsies of advanced EGFR mutated NSCLC patients: A pilot study and a review of the literature 110
Primary atypical carcinoid tumor of the mediastinum: A very rare finding 109
Optimizing PD-L1 evaluation on cytological samples from advanced non-small-cell lung cancer 109
Onset of ANCA-positive EGPA with bilateral pleural effusion: a case report 108
Vulvar acantholytic squamous carcinoma: a case report with immunohistochemical and molecular study. 107
YES1 and MYC Amplifications as Synergistic Resistance Mechanisms to Different Generation ALK Tyrosine Kinase Inhibitors in Advanced NSCLC: Brief Report of Clinical and Preclinical Proofs 107
Phase II, Open-label, Single-arm, Multicenter Study to Assess the Activity and Safety of Alectinib as Neoadjuvant Treatment in Surgically Resectable Stage III ALK-positive NSCLC: ALNEO Trial 106
1061P Static and dynamic tracking of radiomic and immunophenotypic features predicts the benefit of immune checkpoint inhibitors in advanced NSCLC 104
Tubercolosi pleurica multi-resistente in gravidanza: Challenge diagnostico e terapeutico 104
GIANT PRIMARY DEDIFFERENTIATED LIPOSARCOMA OF THE ANTERIOR MEDIASTINUM: AN EXTREMELY RARE OCCURRENCE 104
Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH) Syndrome and Carcinoid Tumors With/Without NECH: A Clinicopathologic, Radiologic, and Immunomolecular Comparison Study 101
Modulating Tumor Microenvironment: A Review on STK11 Immune Properties and Predictive vs Prognostic Role for Non-small-cell Lung Cancer Immunotherapy 100
L718Q Mutation as New Mechanism of Acquired Resistance to AZD9291 in EGFR-Mutated NSCLC 98
Oncocytic mucoepidermoid carcinoma of a submandibular gland: a case report and review of the literature. 97
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights 96
The prognostic value of the haemoglobin/red cell distribution width ratio in a cohort of pre-treated patients with renal cell carcinoma receiving nivolumab 96
Abscopal effect after hypofractionated radiotherapy in metastatic renal cell carcinoma pretreated with pazopanib 96
Lung Manifestation of IgG4-related Disease. A multifaceted disorder. Presentation of two cases and short review of literature 92
Retroperitoneal cystoadenocarcinoma: A case report with a literature review 91
Role of human papillomavirus in the development of epithelial ovarian neoplasms in Italian women 89
Cryptogenic Fibrosing Pleuritis 87
Very late recurrence of an apparently benign pheochromocytoma 85
Spread through air spaces in lung adenocarcinoma: Is radiology reliable yet? 83
Testicular metastasis of prostate adenocarcinoma: the other side of orchiepididymitis 82
NGS detection of gene rearrangements and METexon14 mutations in liquid biopsy of advanced NSCLC patients: A study of two Italian centers 82
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 80
Activity of lenvatinib plus everolimus combination in a heavily pretreated patient with papillary renal cell carcinoma: a case report 78
SOLITARY FIBROUS TUMOR OF THE PLEURA ASSOCIATED WITH SEVERE HYPOGLICEMIA: THE DOEGE-POTTER SYNDROME 76
Malignant deciduoid pleural mesothelioma: A case report 73
Impact of preoperative chemoradiotherapy on tumor infiltrating lymphocytes in locally advanced rectal cancer: The SMART-STAR study 72
7P STK11 and Galectin-3 tissue expression entails a prognostic signature in immunotherapy treated NSCLC patients 72
Influence of preoperative chemoradiation on tumor-infiltrating lymphocytes in locally advanced rectal cancer: The STAR-01 cohort 71
MicroRNA Expression in Malignant Pleural Mesothelioma and Asbestosis: A Pilot Study 71
Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database 71
Therapeutic Outcomes and Clinical Features of Advanced Non-Small Cell Lung Cancer Carrying KRAS Mutations: A Multicenter Real-life Retrospective Study 70
Liquid Biopsy and 18F-FDG PET/CT Derived Parameters as Predictive Factors of Osimertinib Treatment in Advanced EGFR-Mutated NSCLC 67
Intrinsic Resistance to Osimertinib in EGFR Mutated NSCLC Cell Lines Induced by Alteration in Cell-Cycle Regulators 66
MET alterations as resistance mechanisms of dabrafenib-trametinib in BRAF p.V600E mutated non-small cell lung cancer patient 62
Small Cell Lung Cancer Transformation as a Resistance Mechanism to Osimertinib in Epidermal Growth Factor Receptor-Mutated Lung Adenocarcinoma: Case Report and Literature Review 61
Prognostic immunoinflammatory and transcriptomic profiles in patients with pleural mesothelioma undergoing immunotherapy 58
Pazopanib as a possible option for the treatment of metastatic non-clear cell renal carcinoma patients: a systematic review 57
BRAF Fusion as Resistance Mechanism to Osimertinib in EGFR-Mutated NSCLC: A Case Report and Review of Literature 54
CD26 is differentially expressed throughout the life cycle of infantile hemangiomas and characterizes the proliferative phase 51
Identification of a radio-immune signature with high prognostic value in surgically resected NSCLC 43
Multicenter Observational Study on Metastatic Non-Small Cell Lung Cancer Harboring BRAF Mutations: Focus on Clinical Characteristics and Treatment Outcome of V600E and Non-V600E Subgroups 43
Genetic, tissue and circulating PD-L1 profiling to predict the response to immuno-checkpoint inhibitors in advanced NSCLC 42
Plasma exchange-sensitive syncytial glomerulopathy in a kidney transplant patient 42
Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making 30
Totale 10.793
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.526
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.526
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021231 0 0 0 0 0 37 19 24 60 19 49 23
2021/2022403 22 13 5 18 8 13 76 27 20 31 25 145
2022/20231.828 168 240 106 151 151 222 24 125 522 14 76 29
2023/2024841 32 68 14 31 48 176 82 51 50 74 66 149
2024/20252.551 97 124 177 170 271 254 154 125 239 252 223 465
2025/20263.740 555 502 876 688 829 290 0 0 0 0 0 0
Totale 10.793